This is a rare opportunity to acquire an established multi-service Dialysis platform with both inpatient/acute and outpatient capabilities, positioned for growth in a high-demand healthcare segment. This facility was established in 2014, the Company operates a 17-station facility with licensed capacity for 100+ patients and current census of 45 patients, offering meaningful upside through utilization and optimization.

• Comprehensive service mix includes in-center Hemodialysis, Home Hemodialysis support, peritoneal dialysis (CAPD & APD), inpatient/acute dialysis, transplant referrals, and integrated patient support services.
• Diversified care model drives multiple referral pathways and recurring patient engagement, supported by strong physician relationships and community positioning.
• Patient-centered facility emphasizes comfort and experience, enhancing retention in a high-frequency treatment environment.
• Demonstrated adherence to rigorous clinical, quality, and infection control standards aligned with CDC, CMS, and leading regulatory bodies.
• Experienced clinical team and staff expected to remain post-transaction, supporting continuity of care and operational stability.
• Medical Director committed to ongoing involvement as a minority partner, aligning incentives and reducing transition risk. Employees are willing to stay on with new owner.
• Facility operates under a leased model with no known litigation or regulatory issues.
• Significant growth potential through increased Home Dialysis Adoption, expanded referral networks, improved chair utilization, and deeper market penetration.
• Attractive platform opportunity for strategic or financial buyers seeking entry or expansion in dialysis services.
• Very rare, high-demand asset—Dialysis platforms with this level of service breadth, capacity, and continuity are infrequently available.
• Competitive process anticipated; interested parties encouraged to engage promptly.
All interested parties must sign a non-disclosure and must show proof of financial viability.